Kley in Davos

More than 2,500 participants from the worlds of business, politics, science and culture as well as representatives of international organizations attended the annual meeting of the World Economic Forum this week. Besides discussing topics that Merck KGaA, Darmstadt, Germany, can make a positive contribution to, CEO Karl-Ludwig Kley shared his views on current economic challenges and the future development of Merck KGaA, Darmstadt, Germany, in various media interviews.

Consumer Health Division Sparks Debate on the Future of the OTC Sector

November 28, 2014 – Our Consumer Health division hosted a top level debate on key future aspects of the OTC sector, in London. Featuring contributions from leading analysts, professional representatives and patient groups, the event combined the experience and views of Merck Consumer Health’s senior management team with external perspectives on the major pressures and influences facing the industry.

Global Strategic Alliance with Pfizer on Anti-PD-L1 to Accelerate Presence in Immuno-Oncology

November 17, 2014 – Merck KGaA, Darmstadt, Germany, and Pfizer entered into a global agreement to co-develop and co-commercialize our investigational anti-PD-L1 antibody as a potential treatment for multiple tumor types to accelerate the two companies’ presence in immuno-oncology.
As part of the agreement, Merck KGaA, Darmstadt, Germany, will co-promote Pfizer’s Xalkori, a medicine to treat non-small cell lung cancer, in the United States and several other key markets.

Access to Medicine Index: Merck KGaA, Darmstadt, Germany, in sixth place

Darmstadt, Germany, November 18, 2014 – Merck KGaA, Darmstadt, Germany, announced today that it now ranks sixth in the Access to Medicine Index published yesterday by the Access to Medicine Foundation. Merck KGaA, Darmstadt, Germany, has moved up two places compared to the 2012 ranking. This improvement underlines the company’s commitment to helping overcome barriers to access for underserved populations and communities in low- and middle-income countries as part of its corporate responsibility and sustainable business approach. Every two years, the Access to Medicine Index benchmarks the top pharmaceutical companies on activities and initiatives that are advancing access to medicines in developing countries.

Merck KGaA, Darmstadt, Germany, reports strong top-line growth in the third quarter

"We are gearing up for a strong finish in 2014. All our businesses are performing well and contributed to across-the-board growth in the third quarter," said Karl-Ludwig Kley, Chairman of the Executive Board of Merck KGaA, Darmstadt, Germany.

Displaying Futures – How displays influence architecture

Merck KGaA, Darmstadt, Germany, is holding its “Displaying Futures”’ symposium in Shanghai, China on November 6, 2014. Focusing on the theme “Building Innovation – Displaying Architecture”, experts will discuss questions concerning the impact of innovative display solutions on architecture as well as the life of the people therein. The Displaying Futures Shanghai symposium is the fourth in a series of annual symposia held since 2011, in which Merck KGaA, Darmstadt, Germany, has set out to explore new avenues through an inspiring exchange between designers, artists, communications experts, architects and scientists.

 

Media Services for the US and Canada – News starting 2013, Dates & Publications

Latest Press Releases
Merck KGaA, Darmstadt, Germany, Strengthens Presence as Leading Oncology Company by Taking Full Promotional Responsibility for Erbitux in Japan
Merck KGaA, Darmstadt, Germany, Strengthens Presence as Leading Oncology Company by Taking Full Promotional Responsibility for Erbitux in Japan
Darmstadt, Germany, February 13, 2015 – Merck KGaA, Darmstadt, Germany, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials today announced that Merck KGaA, Darmstadt, Germany, and Bristol-Myers Squibb have agreed to transfer full responsibility for the promotion of Erbitux® (cetuximab) to Merck KGaA, Darmstadt, Germany, in Japan as of May 1, 2015.
 
Glucophage®
Merck KGaA, Darmstadt, Germany, Repatriates Diabetes and Thyroids Portfolio in Russia to Continue to Drive Emerging Markets Strategy
Darmstadt, Germany, February 2, 2015 – Merck KGaA, Darmstadt, Germany today announced the repatriation of all responsibility for its diabetes and thyroid brands in Russia back to the company. The move, effective as of January 1, 2015, transfers all activities for these brands from the company’s marketing partner Takeda Pharmaceutical Company Limited back to the company’s business in Russia.
 
Andreas Stickler and Roman Morten Werth
Andreas Stickler and Roman Morten Werth
Merck KGaA, Darmstadt, Germany, Announces Personnel Changes in Finance Function
Darmstadt, Germany, January 30, 2015 – Merck KGaA, Darmstadt, Germany, today announced that Andreas Stickler (43) has been appointed as new Head of Controlling of the Healthcare Business Sector. Roman Morten Werth (38) will succeed Andreas Stickler in his current position as Head of Mergers & Acquisitions (M&A).
 
 
top

OUR COMPANY IN THE MEDIA

OUR COMPANY IN THE MEDIA
Read how Merck KGaA, Darmstadt, Germany, and its affiliates are covered by media outlets around the world

DOWNLOAD LIBRARY

Download Library
Download images, Media Kits and other material from our media download library

CALENDAR OF EVENTS

Calendar of Events
Find and register for upcoming events

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
In the United States and Canada the subsidiaries of Merck KGaA, Darmstadt, Germany, operate under the umbrella brand EMD.
 

CONTACTS FOR JOURNALIST INQUIRIES

Media Team
POSTAL ADDRESS 
Merck KGaA 
Frankfurter Straße 250 
64293 Darmstadt 
Germany
Tel.: +49 6151 72-5000
Fax: +49 6151 72-3138
 

GENERAL INQUIRIES

Communications Center
Tel.: +49 6151 72-0
Fax: +49 6151 72-2000
 

FINANCIAL REPORT

3rd quarter 2014Interim Report
Merck on Facebook
Merck on Twitter
 
  
Read more on M - The Explorer Magazine

A startup workshop gets ideas rolling

On the bus heading from Tanzania to Rwanda are 37 young people. This is not a pleasure trip - it is a startup workshop on wheels that is supported by many companies including us.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

Patients as heroes

Participants in clinical trials play a key role in medical progress. Our company expressly appreciates their commitment and relies on this partnership, which is based on close collaboration.

Read more on M - The Explorer Magazine